These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12544385)

  • 1. Efficacy of clozapine in the treatment of atypical antipsychotic refractory schizophrenia: a pilot study.
    Narendran R; Young CM; Pristach CA; Pato MT; Valenti AM; Fass AR
    J Clin Psychopharmacol; 2003 Feb; 23(1):103-4. PubMed ID: 12544385
    [No Abstract]   [Full Text] [Related]  

  • 2. Very high cytochrome P4501A2 activity and nonresponse to clozapine.
    Bender S; Eap CB
    Arch Gen Psychiatry; 1998 Nov; 55(11):1048-50. PubMed ID: 9819075
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment-refractory schizophrenia in children and adolescents: an update on clozapine and other pharmacologic interventions.
    Kranzler HN; Kester HM; Gerbino-Rosen G; Henderson IN; Youngerman J; Beauzile G; Ditkowsky K; Kumra S
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):135-59. PubMed ID: 16321728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between delay in initiating clozapine and symptomatic improvement.
    Yada Y; Yoshimura B; Kishi Y
    Schizophr Res; 2015 Oct; 168(1-2):585-6. PubMed ID: 26255084
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effectiveness of clozapine for patients nonresponsive to or intolerant of first generation antipsychotic medications.
    Jackson CT; Covell NH; Essock SM
    Schizophr Bull; 2004; 30(2):219-27. PubMed ID: 15279041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Clozapine Level Following Acute Infection in a Patient with Schizophrenia: a Case Report.
    Poon JYK; Tang DYY; Siu BWM; Lui SH
    East Asian Arch Psychiatry; 2020 Dec; 30(4):120-121. PubMed ID: 33349619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy.
    Khodayari-Rostamabad A; Hasey GM; Maccrimmon DJ; Reilly JP; de Bruin H
    Clin Neurophysiol; 2010 Dec; 121(12):1998-2006. PubMed ID: 21035741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine with amisulpride for refractory schizophrenia.
    Agelink MW; Kavuk I; Ak I
    Am J Psychiatry; 2004 May; 161(5):924-5. PubMed ID: 15121665
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine. A novel antipsychotic agent.
    Baldessarini RJ; Frankenburg FR
    N Engl J Med; 1991 Mar; 324(11):746-54. PubMed ID: 1671793
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clozapine in treatment of neuropsychiatric diseases in the elderly].
    Retz W; Rösler M; Sitzmann L; Becker T
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):347-53. PubMed ID: 9378447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.
    Bitter I; Dossenbach MR; Brook S; Feldman PD; Metcalfe S; Gagiano CA; Füredi J; Bartko G; Janka Z; Banki CM; Kovacs G; Breier A;
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):173-80. PubMed ID: 14687871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Srivastava A; Jacob M; Jacob KS
    Psychopharmacology (Berl); 2012 Dec; 224(3):441-9. PubMed ID: 22700043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clozapine--an atypical neuroleptic with a unique clinical profile].
    Lindström L; Lundberg T
    Lakartidningen; 1992 Jun; 89(26-27):2368-72. PubMed ID: 1354777
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of a clozapine trial in neuroleptic-resistant schizophrenia.
    Meltzer HY
    Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.